First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.
Clin Cancer Res
; 25(22): 6590-6597, 2019 11 15.
Article
in En
| MEDLINE
| ID: mdl-31427282
Full text:
1
Database:
MEDLINE
Main subject:
Radiotherapy
/
Glioblastoma
/
Antineoplastic Agents, Alkylating
/
Temozolomide
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article